Analytical Data
-
Gene name
PLAC1
- Application
-
Alternative Names
/
-
Species
Human
-
Source
E. coli
-
Tag
N- His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9HBJ0
-
Expression Region
23-212aa
-
Molecular Weight
23.3 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
PLAC1 (Placenta-specific 1) is a gene initially identified for its expression during early placentation and trophoblast development. Research has revealed that it is not only crucial for normal placental function but may also play significant roles in various pathological conditions, including cancer. The protein encoded by PLAC1 is known to be involved in cellular processes such as proliferation, differentiation, and immune modulation, making it a potential biomarker and therapeutic target. High expression levels of PLAC1 have been correlated with poor prognosis in several cancer types, indicating that it may contribute to tumor growth and metastasis. Consequently, recombinant PLAC1 protein has garnered attention for its applications in understanding these mechanisms. Studies utilizing this protein aim to elucidate its functions in both normal physiology and disease contexts, thereby providing insights into its potential as a target for novel immunotherapies. Furthermore, investigations into PLAC1's interactions and signaling pathways may advance the development of new diagnostic tools and treatments, enhancing our understanding of its role in reproductive health and oncology. As such, the exploration of recombinant PLAC1 not only contributes to basic research but also holds promise for translational applications in medicine.
